See veebileht kasutab küpsiseid kasutaja sessiooni andmete hoidmiseks. Veebilehe kasutamisega nõustute ETISe kasutustingimustega. Loe rohkem
Olen nõus
"Muu" projekt MP1GV07244R
MP1GV07244R "Biobanking and Biomolecular Resources Research Infrastructure (8.02.2008−7.05.2010)", Andres Metspalu, Tartu Ülikool, Tartu Ülikool, Tartu Ülikooli Eesti Geenivaramu.
MP1GV07244R
Biobanking and Biomolecular Resources Research Infrastructure
8.02.2008
7.05.2010
Teadus- ja arendusprojekt
Muu
ValdkondAlamvaldkondCERCS erialaFrascati Manual’i erialaProtsent
1. Bio- ja keskkonnateadused1.3. GeneetikaB220 Geneetika, tsütogeneetika 1.5. Bioteadused (bioloogia, botaanika, bakterioloogia, mikrobioloogia, zooloogia, entomoloogia, geneetika, biokeemia, biofüüsika jt100,0
AsutusRollPeriood
Tartu Ülikoolpartner08.02.2008−07.05.2010
Tartu Ülikool, Tartu Ülikooli Eesti Geenivaramupartner08.02.2008−07.05.2010
AsutusRiikTüüp
Euroopa Komisjon
PerioodSumma
08.02.2008−07.05.2010591 535,00 EEK (37 805,98 EUR)
37 805,98 EUR
0,00 EUR
7. raamprogramm

Biobanking and Biomolecular Resources Research Infrastructure. The work in the preparatory phase will mainly build on achievements of previous and ongoing national, European and global projects and initiatives, such as research projects funded in FP5 and FP6 and on new projects within FP7 which are directly related to the needs of BBMRI, work on biobank harmonization done by the P3G consortium, the strategic research agenda of the Innovative Medicines Initiatives, the WHO, and the OECD initiative on a global network of Biological Resource Centres. Key components of BBMRI are comprehensive collections of biological samples from different populations of Europe, which should be linked with continuously updated data on the health status, lifestyle and environmental exposure of the sample donors.BBMRI will build on existing sample collections, resources, technologies, and expertise, which will be specifically complemented with innovative components and will be properly embedded into European ethical, legal and societal frameworks. Sustainability will be achieved by appropriate funding and financing solutions. BBMRI will increase the scientific excellence and efficacy of European research in the biomedical sciences as well as expand and secure competitiveness of European research and industry in a global context.
Biobanking and Biomolecular Resources Research Infrastructure. The work in the preparatory phase will mainly build on achievements of previous and ongoing national, European and global projects and initiatives, such as research projects funded in FP5 and FP6 and on new projects within FP7 which are directly related to the needs of BBMRI, work on biobank harmonization done by the P3G consortium, the strategic research agenda of the Innovative Medicines Initiatives, the WHO, and the OECD initiative on a global network of Biological Resource Centres. Key components of BBMRI are comprehensive collections of biological samples from different populations of Europe, which should be linked with continuously updated data on the health status, lifestyle and environmental exposure of the sample donors.BBMRI will build on existing sample collections, resources, technologies, and expertise, which will be specifically complemented with innovative components and will be properly embedded into European ethical, legal and societal frameworks. Sustainability will be achieved by appropriate funding and financing solutions. BBMRI will increase the scientific excellence and efficacy of European research in the biomedical sciences as well as expand and secure competitiveness of European research and industry in a global context.